LENSAR, Inc. (LNSR)
NCM · Healthcare · Medical Devices
Closing price as of 2026-09-11 · Source: TEK2day Finance
Key Metrics
About LENSAR, Inc.
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
Quarterly Financials
| Metric | 2025-09-30 | 2025-12-31 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|
| Revenue | 14.3M | 16.0M | 13.4M | 16.5M |
| Gross Profit | 6.0M | 6.9M | 6.4M | 9.8M |
| Operating Income | (7.6M) | (4.9M) | 2.2M | 2.1M |
| Net Income | (3.7M) | (1.5M) | 36.3M | 3.5M |
| Diluted EPS | $-0.31 | $-0.12 | $0.00 | $0.10 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 35.4M | 42.2M | 53.5M | 58.4M |
| Gross Profit | 20.0M | 21.1M | 25.9M | 27.1M |
| Operating Income | (20.2M) | (12.2M) | (6.9M) | (24.6M) |
| Net Income | (19.9M) | (14.4M) | (31.4M) | (34.3M) |
| Diluted EPS | $-1.96 | $-1.31 | $-2.73 | $-2.87 |